Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Healthy Volunteers
Interventions
DRUG

DA-3031

DRUG

Filgrastim

Trial Locations (1)

110-744

Clinical Trials center, Clinical Research institute, Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT00959777 - Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers | Biotech Hunter | Biotech Hunter